Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 19, 2015 16:07 ET | Source: Galapagos NV

Galapagos raises EU4.4 million through warrant exercises

MECHELEN, Belgium, June 19, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext:GLPG) (Nasdaq:GLPG) announced today a share capital increase arising from warrant exercises. Since its inception in 1999,...
June 19, 2015 16:00 ET | Source: Galapagos NV

Galapagos haalt €4,4 miljoen op door uitoefening van warrants

Mechelen, België; 19 juni 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag een kapitaalverhoging aan als gevolg van de uitoefening van warrants. Sinds haar oprichting in 1999...
June 19, 2015 16:00 ET | Source: Galapagos NV

Galapagos raises €4.4 million through warrant exercises

Mechelen, Belgium; 19 June 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) announced today a share capital increase arising from warrant exercises. Since its inception in 1999, Galapagos has...
June 18, 2015 01:30 ET | Source: Galapagos NV

Galapagos rondt werving van patiënten af voor ORIGIN Fase 2 klinische studie met GLPG1205 bij colitis ulcerosa patiënten

Mechelen, België; 18 juni 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat de werving van patiënten voor de Fase 2 klinische studie met GLPG1205 bij colitis ulcerosa...
June 18, 2015 01:30 ET | Source: Galapagos NV

Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients

Mechelen, Belgium; 18 June 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) announced today it has completed recruitment for the Phase 2 Proof-of-Concept study in ulcerative colitis with GPR84...
June 15, 2015 01:30 ET | Source: Galapagos NV

AbbVie en Galapagos presenteren resultaten taaislijmziekte (CF) onderzoek op ECFS conferentie

Mechelen, België; 15 juni 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) presenteert samen met AbbVie (NYSE: ABBV) resultaten tijdens de 38e jaarlijkse European Cystic Fibrosis Society...
June 15, 2015 01:30 ET | Source: Galapagos NV

AbbVie and Galapagos present cystic fibrosis corrector and potentiator screening approach at ECFS conference

Mechelen, Belgium; 15 June 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) announced a joint presentation with AbbVie (NYSE: ABBV) at the 38th annual European Cystic Fibrosis Society conference in...
June 10, 2015 01:30 ET | Source: Galapagos NV

Galapagos DARWIN 1 en 2 patiëntenstudies van 24 weken afgerond

Laatste van de 886 reuma-patiënten zijn klaar met de 24 weken behandelingResultaten worden in juli en augustus bekendgemaakt Mechelen, België; 10 juni 2015 - Galapagos NV (Euronext & NASDAQ:...
June 10, 2015 01:30 ET | Source: Galapagos NV

Galapagos DARWIN 1 and 2 studies have completed 24 weeks of treatment

Last of 886 enrolled rheumatoid arthritis (RA) patients have completed the 24 week visit Topline results from final analyses expected to be released in July and August 2015 Mechelen, Belgium; 10...
May 26, 2015 16:00 ET | Source: Galapagos NV

Galapagos receives transparency notifications

Mechelen, Belgium; 26 May 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from the Capital Group Companies, Inc., Fidelity Management and Research LLC, and...